Eagle Pharmaceuticals
EGRX
#9841
Rank
C$32.3 M
Marketcap
$2.49
Share price
0.00%
Change (1 day)
-59.59%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): C$47.96 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are C$0.25 Billion. In 2022 the company made an earning of C$91.22 Million, an increase over its 2021 earnings that were of -C$4.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) C$47.96 M-47.42%
2022 C$91.22 M-2361.45%
2021 -C$4.04 Million-111.53%
2020 C$34.97 M2.31%
2019 C$34.18 M-32.89%
2018 C$50.93 M-50.35%
2017 C$0.10 B38.63%
2016 C$74 M1966.43%
2015 C$3.58 M-111.46%
2014 -C$31.26 Million282.82%
2013 -C$8.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$24.15 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.08 B 12,223.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$18.88 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-C$0.4 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$6.38 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.55 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.61 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA